SC-79 was used as an agonist of PI3K/AKT/mTOR PTEN-Akt and other pathways in bladder epithelial cancer cells, human glioblastoma cells, human gastric cancer cells, and pancreatic ductal cancer cells [22, 23]. This evidence concerns the gene MTOR and glioblastoma.